(Q39458253)

12 September 2017

title

Inhibition of autoimmune diabetes by TLR2 tolerance (English)

1 reference

12 September 2017

Inhibition of Autoimmune Diabetes by TLR2 Tolerance (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

14 December 2024

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21998452

14 December 2024

author name string

Do-Hoon Kim

1

1 reference

12 September 2017

June-Chul Lee

2

1 reference

12 September 2017

Sunshin Kim

3

1 reference

12 September 2017

Seung Hoon Oh

4

1 reference

12 September 2017

Moon-Kyu Lee

5

1 reference

12 September 2017

Kwang-Won Kim

6

1 reference

12 September 2017

Myung-Shik Lee

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

12 October 2011

1 reference

12 September 2017

published in

Journal of Immunology

1 reference

12 September 2017

volume

187

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

5211-5220

1 reference

Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?

12 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Physiological β Cell Death Triggers Priming of Self-reactive T Cells by Dendritic Cells in a Type-1 Diabetes Model

14 December 2024

2

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes

14 December 2024

3

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1.

14 December 2024

5

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death

14 December 2024

6

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Essential role of STAT1 in caspase-independent cell death of activated macrophages through the p38 mitogen-activated protein kinase/STAT1/reactive oxygen species pathway

14 December 2024

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice

14 December 2024

8

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope

14 December 2024

9

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved

14 December 2024

10

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia

14 December 2024

11

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide

14 December 2024

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression

14 December 2024

14

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Prolonged Toll-like receptor stimulation leads to down-regulation of IRAK-4 protein

14 December 2024

15

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

IRAK-M is a negative regulator of Toll-like receptor signaling

14 December 2024

16

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model

14 December 2024

17

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation.

14 December 2024

18

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Cutting edge: TLR2 directly triggers Th1 effector functions

14 December 2024

19

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Toll-like receptor 2 controls expansion and function of regulatory T cells

14 December 2024

20

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes

14 December 2024

21

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7

14 December 2024

22

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

14 December 2024

23

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages

14 December 2024

24

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation

14 December 2024

25

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

14 December 2024

26

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Gene-specific control of inflammation by TLR-induced chromatin modifications

14 December 2024

27

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

14 December 2024

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components

14 December 2024

29

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Immunostimulation circumvents diabetes in NOD/Lt mice

14 December 2024

30

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity

14 December 2024

31

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes

14 December 2024

32

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Limited effect of CpG ODN in preventing type 1 diabetes in NOD mice

14 December 2024

33

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes.

14 December 2024

34

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Roles for TGF-beta and programmed cell death 1 ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic mice

14 December 2024

35

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.

14 December 2024

36

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Fungal zymosan and mannan activate the cryopyrin inflammasome

14 December 2024

37

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model.

14 December 2024

38

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice

14 December 2024

39

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Triggering TLR signaling in vaccination

14 December 2024

40

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

14 December 2024

Q24291418

41

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer

14 December 2024

42

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

14 December 2024

43

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview

14 December 2024

44

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

14 December 2024

45

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes

14 December 2024

46

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice

14 December 2024

47

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity

14 December 2024

48

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Histopathological studies on the local reactions induced by complete Freund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugates

14 December 2024

49

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Evaluation of a Lipopeptide Immunogen as a Therapeutic in HIV Type 1-Seropositive Individuals

14 December 2024

50

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

14 December 2024

51

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes

14 December 2024

52

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

14 December 2024

53

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.1001388

14 December 2024

Identifiers

1 reference

12 September 2017

1 reference